Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


26.03.2018

1 Alzheimer Dis Assoc Disord
2 Alzheimers Dement
36 J Alzheimers Dis
2 J Neurosci
1 JAMA
1 Lancet Neurol
1 N Engl J Med
1 Nat Neurosci
1 Neurobiol Aging
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. BRADFIELD NI, Ellis KA, Savage G, Maruff P, et al
    Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Alzheimer Dis Assoc Disord. 2018 Mar 20. doi: 10.1097/WAD.0000000000000252.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  2. SMITH RG, Hannon E, De Jager PL, Chibnik L, et al
    Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Mar 14. pii: S1552-5260(18)30049.
    PubMed     Text format     Abstract available

  3. CONNORS MH, Seeher KM, Crawford J, Ames D, et al
    The stability of neuropsychiatric subsyndromes in Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 13. pii: S1552-5260(18)30048.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  4. DRUMMOND E, Goni F, Liu S, Prelli F, et al
    Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179909. doi: 10.3233/JAD-179909.
    PubMed     Text format     Abstract available

  5. PARNETTI L, Eusebi P
    Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179910. doi: 10.3233/JAD-179910.
    PubMed     Text format     Abstract available

  6. CLARKE JR, Ribeiro FC, Frozza RL, De Felice FG, et al
    Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179911. doi: 10.3233/JAD-179911.
    PubMed     Text format     Abstract available

  7. MCGEER PL, McGeer E
    Conquering Alzheimer's Disease by Self Treatment.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179913. doi: 10.3233/JAD-179913.
    PubMed     Text format     Abstract available

  8. GUTIERREZ A, Vitorica J
    Toward a New Concept of Alzheimer's Disease Models: A Perspective from Neuroinflammation.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179914. doi: 10.3233/JAD-179914.
    PubMed     Text format     Abstract available

  9. HERNANDEZ F, Llorens-Martin M, Bolos M, Perez M, et al
    New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179916. doi: 10.3233/JAD-179916.
    PubMed     Text format     Abstract available

  10. TEIXEIRA CM, Pallas-Bazarra N, Bolos M, Terreros-Roncal J, et al
    Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179918. doi: 10.3233/JAD-179918.
    PubMed     Text format     Abstract available

  11. NISBET RM, Gotz J
    Amyloid-beta and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179907. doi: 10.3233/JAD-179907.
    PubMed     Text format     Abstract available

  12. MECOCCI P, Baroni M, Senin U, Boccardi V, et al
    Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179903. doi: 10.3233/JAD-179903.
    PubMed     Text format     Abstract available

  13. CUMMINGS J, Ritter A, Zhong K
    Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179901. doi: 10.3233/JAD-179901.
    PubMed     Text format     Abstract available

  14. STIPHO F, Jackson R, Sabbagh MN
    Pathologically Confirmed Alzheimer's Disease in APOE varepsilon2 Homozygotes is Rare but Does Occur.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD171060. doi: 10.3233/JAD-171060.
    PubMed     Text format     Abstract available

  15. COURTEMANCHE H, Bigot E, Pichelin M, Guyomarch B, et al
    PCSK9 Concentrations in Cerebrospinal Fluid Are Not Specifically Increased in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170993. doi: 10.3233/JAD-170993.
    PubMed     Text format     Abstract available

  16. HIRANO S, Shinotoh H, Shimada H, Ota T, et al
    Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170749. doi: 10.3233/JAD-170749.
    PubMed     Text format     Abstract available

  17. PENNY W, Iglesias-Fuster J, Quiroz YT, Lopera FJ, et al
    Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170405. doi: 10.3233/JAD-170405.
    PubMed     Text format     Abstract available

  18. KWAK K, Yun HJ, Park G, Lee JM, et al
    Multi-Modality Sparse Representation for Alzheimer's Disease Classification.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170338. doi: 10.3233/JAD-170338.
    PubMed     Text format     Abstract available

  19. SUHONEN NM, Haanpaa RM, Korhonen V, Jokelainen J, et al
    Neuropsychological Profile in the C9ORF72 Associated Behavioral Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161142.
    PubMed     Text format     Abstract available

  20. BALMIK AA, Chinnathambi S
    Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170900. doi: 10.3233/JAD-170900.
    PubMed     Text format     Abstract available

  21. GONG CX, Liu F, Iqbal K
    Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179921. doi: 10.3233/JAD-179921.
    PubMed     Text format     Abstract available

  22. HAMPEL H, Toschi N, Babiloni C, Baldacci F, et al
    Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179932. doi: 10.3233/JAD-179932.
    PubMed     Text format     Abstract available

  23. YAN T, Wang L, Gao J, Siedlak SL, et al
    Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD180023. doi: 10.3233/JAD-180023.
    PubMed     Text format     Abstract available

  24. MECOCCI P, Boccardi V, Cecchetti R, Bastiani P, et al
    A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.
    J Alzheimers Dis. 2018;62:1319-1335.
    PubMed     Text format     Abstract available

  25. MARTINS RN, Villemagne V, Sohrabi HR, Chatterjee P, et al
    Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.
    J Alzheimers Dis. 2018;62:965-992.
    PubMed     Text format     Abstract available

  26. KEHOE PG
    The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
    J Alzheimers Dis. 2018;62:1443-1466.
    PubMed     Text format     Abstract available

  27. MOREIRA PI
    Sweet Mitochondria: A Shortcut to Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:1391-1401.
    PubMed     Text format     Abstract available

  28. BOADA M, Santos-Santos MA, Rodriguez-Gomez O, Alegret M, et al
    Patient Engagement: The Fundacio ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2018;62:1079-1090.
    PubMed     Text format     Abstract available

  29. BAAZAOUI N, Iqbal K
    A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.
    J Alzheimers Dis. 2018;62:1211-1218.
    PubMed     Text format     Abstract available

  30. DE LA MONTE SM, Tong M, Wands JR
    The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.
    J Alzheimers Dis. 2018;62:1381-1390.
    PubMed     Text format     Abstract available

  31. FORLONI G, Balducci C
    Alzheimer's Disease, Oligomers, and Inflammation.
    J Alzheimers Dis. 2018;62:1261-1276.
    PubMed     Text format     Abstract available

  32. BLENNOW K, Zetterberg H
    The Past and the Future of Alzheimer's Disease Fluid Biomarkers.
    J Alzheimers Dis. 2018;62:1125-1140.
    PubMed     Text format     Abstract available

  33. FENOGLIO C, Scarpini E, Serpente M, Galimberti D, et al
    Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2018;62:913-932.
    PubMed     Text format     Abstract available

  34. MOLINUEVO JL, Minguillon C, Rami L, Gispert JD, et al
    The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.
    J Alzheimers Dis. 2018;62:1067-1077.
    PubMed     Text format     Abstract available

  35. BJERKE M, Engelborghs S
    Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2018;62:1199-1209.
    PubMed     Text format     Abstract available

  36. GRINAN-FERRE C, Corpas R, Puigoriol-Illamola D, Palomera-Avalos V, et al
    Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.
    J Alzheimers Dis. 2018;62:943-963.
    PubMed     Text format     Abstract available

  37. ADLARD PA, Bush AI
    Metals and Alzheimer's Disease: How Far Have We Come in the Clinic?
    J Alzheimers Dis. 2018;62:1369-1379.
    PubMed     Text format     Abstract available

  38. BUTTERFIELD DA, Boyd-Kimball D
    Oxidative Stress, Amyloid-beta Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:1345-1367.
    PubMed     Text format     Abstract available

  39. SHI L, Baird AL, Westwood S, Hye A, et al
    A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
    J Alzheimers Dis. 2018;62:1181-1198.
    PubMed     Text format     Abstract available


    J Neurosci

  40. VANDERHEYDEN WM, Lim MM, Musiek ES, Gerstner JR, et al
    Alzheimer's Disease and Sleep-Wake Disturbances: Amyloid, Astrocytes, and Animal Models.
    J Neurosci. 2018;38:2901-2910.
    PubMed     Text format     Abstract available

  41. RAJENDRAN L, Paolicelli RC
    Microglia-Mediated Synapse Loss in Alzheimer's Disease.
    J Neurosci. 2018;38:2911-2919.
    PubMed     Text format     Abstract available


    JAMA

  42. ABBASI J
    Plasma Biomarkers Predict Brain Amyloid-beta Burden.
    JAMA. 2018;319:972.
    PubMed     Text format    


    Lancet Neurol

  43. VAN DER LEE SJ, Wolters FJ, Ikram MK, Hofman A, et al
    The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    Lancet Neurol. 2018 Mar 16. pii: S1474-4422(18)30053.
    PubMed     Text format     Abstract available


    N Engl J Med

  44. DEVI G
    Alzheimer's Disease in Physicians - Assessing Professional Competence and Tempering Stigma.
    N Engl J Med. 2018;378:1073-1075.
    PubMed     Text format    


    Nat Neurosci

  45. NATIVIO R, Donahue G, Berson A, Lan Y, et al
    Publisher Correction: Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease.
    Nat Neurosci. 2018 Mar 19. pii: 10.1038/s41593-018-0124.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  46. SASSI C, Nalls MA, Ridge PG, Gibbs JR, et al
    Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3.
    Neurobiol Aging. 2018 Feb 2. pii: S0197-4580(18)30023.
    PubMed     Text format     Abstract available


    PLoS One

  47. HOUMANI N, Vialatte F, Gallego-Jutgla E, Dreyfus G, et al
    Diagnosis of Alzheimer's disease with Electroencephalography in a differential framework.
    PLoS One. 2018;13:e0193607.
    PubMed     Text format     Abstract available

  48. WHITE MR, Kandel R, Hsieh IN, De Luna X, et al
    Critical role of C-terminal residues of the Alzheimer's associated beta-amyloid protein in mediating antiviral activity and modulating viral and bacterial interactions with neutrophils.
    PLoS One. 2018;13:e0194001.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: